1115 related articles for article (PubMed ID: 18400254)
61. Low-grade myofibroblastic sarcoma of the oral cavity.
Demarosi F; Bay A; Moneghini L; Carrassi A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Aug; 108(2):248-54. PubMed ID: 19615664
[TBL] [Abstract][Full Text] [Related]
62. Inflammatory myofibroblastic tumour of the urinary bladder: the role of immunoglobulin G4 and the comparison of two immunohistochemical antibodies and fluorescence in-situ hybridization for the detection of anaplastic lymphoma kinase alterations.
Choi E; Williamson SR; Montironi R; Zhang S; Wang M; Eble JN; Grignon DJ; Lopez-Beltran A; Idrees MT; Baldridge LA; Scarpelli M; Jones CL; Wang L; MacLennan GT; Osunkoya AO; Cheng L
Histopathology; 2015 Jul; 67(1):20-38. PubMed ID: 25406945
[TBL] [Abstract][Full Text] [Related]
63. ALK expression in pseudosarcomatous myofibroblastic proliferations of the genitourinary tract.
Hirsch MS; Dal Cin P; Fletcher CD
Histopathology; 2006 Apr; 48(5):569-78. PubMed ID: 16623783
[TBL] [Abstract][Full Text] [Related]
64. Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group.
Guillou L; Benhattar J; Gengler C; Gallagher G; Ranchère-Vince D; Collin F; Terrier P; Terrier-Lacombe MJ; Leroux A; Marquès B; Aubain Somerhausen Nde S; Keslair F; Pedeutour F; Coindre JM
Am J Surg Pathol; 2007 Sep; 31(9):1387-402. PubMed ID: 17721195
[TBL] [Abstract][Full Text] [Related]
65. Fibronexus in low-grade myofibrosarcoma: a case report.
Watanabe K; Tanaka M; Takashi K; Yamada H; Tajino T
Ultrastruct Pathol; 2008; 32(3):97-100. PubMed ID: 18570154
[TBL] [Abstract][Full Text] [Related]
66. Rare presentation of inflammatory myofibroblastic tumor on a digit.
West CE; Workman A; Moody T; Hosler GA
J Cutan Pathol; 2021 Jul; 48(7):965-968. PubMed ID: 33754372
[TBL] [Abstract][Full Text] [Related]
67. [Dedifferentiated liposarcoma with inflammatory myofibroblastic tumor-like features: a clinicopathological analysis of five cases].
Si HP; Wang Z; Fan QH; Zhang YF; Yang DQ; Zhang ZH; Gong QX
Zhonghua Bing Li Xue Za Zhi; 2019 Apr; 48(4):282-287. PubMed ID: 30955263
[No Abstract] [Full Text] [Related]
68. [Clinicopathologic features and immunophenotype of pseudosarcomatous myofibroblastic proliferation of urinary bladder].
Zhang YH; Zhang XR; Yu J; Li HL
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):585-590. PubMed ID: 30107662
[No Abstract] [Full Text] [Related]
69. Fibronexus in "malignant fibrous histiocytoma" of the bone: a case report of pleomorphic myofibrosarcoma.
Watanabe K; Ogura G
Ultrastruct Pathol; 2002; 26(1):47-51. PubMed ID: 12028659
[TBL] [Abstract][Full Text] [Related]
70. ALK Immunoexpression is Specific for Inflammatory Myofibroblastic Tumor Among Vulvovaginal Mesenchymal Neoplasms.
Bowman CJ; Medeiros F; Fadare O; Sangoi AR; Horvai AE; Devine WP; McCluggage WG; Rabban JT
Int J Gynecol Pathol; 2023 Jan; 42(1):1-10. PubMed ID: 35180768
[TBL] [Abstract][Full Text] [Related]
71. Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor.
Ma Z; Hill DA; Collins MH; Morris SW; Sumegi J; Zhou M; Zuppan C; Bridge JA
Genes Chromosomes Cancer; 2003 May; 37(1):98-105. PubMed ID: 12661011
[TBL] [Abstract][Full Text] [Related]
72. Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors.
Rabban JT; Zaloudek CJ; Shekitka KM; Tavassoli FA
Am J Surg Pathol; 2005 Oct; 29(10):1348-55. PubMed ID: 16160478
[TBL] [Abstract][Full Text] [Related]
73. Ossifying fibromyxoid tumor: modified myoepithelial cell tumor? Report of three cases with immunohistochemical and electron microscopic studies.
Min KW; Seo IS; Pitha J
Ultrastruct Pathol; 2005; 29(6):535-48. PubMed ID: 16316954
[TBL] [Abstract][Full Text] [Related]
74. Claudin-1 is expressed in perineurioma-like low-grade fibromyxoid sarcoma.
Thway K; Fisher C; Debiec-Rychter M; Calonje E
Hum Pathol; 2009 Nov; 40(11):1586-90. PubMed ID: 19540561
[TBL] [Abstract][Full Text] [Related]
75. Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors.
Hornick JL; Sholl LM; Dal Cin P; Childress MA; Lovly CM
Mod Pathol; 2015 May; 28(5):732-9. PubMed ID: 25612511
[TBL] [Abstract][Full Text] [Related]
76. Intraosseous inflammatory myofibroblastic tumor of the mandible with a novel ATIC-ALK fusion mutation: a case report.
Tateishi Y; Okudela K; Kawai S; Suzuki T; Umeda S; Matsumura M; Kioi M; Ohashi K
Diagn Pathol; 2016 Nov; 11(1):132. PubMed ID: 27846861
[TBL] [Abstract][Full Text] [Related]
77. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor.
Bridge JA; Kanamori M; Ma Z; Pickering D; Hill DA; Lydiatt W; Lui MY; Colleoni GW; Antonescu CR; Ladanyi M; Morris SW
Am J Pathol; 2001 Aug; 159(2):411-5. PubMed ID: 11485898
[TBL] [Abstract][Full Text] [Related]
78. Pediatric inflammatory myofibroblastic tumor: anaplastic lymphoma kinase (ALK) expression and prognosis.
Chun YS; Wang L; Nascimento AG; Moir CR; Rodeberg DA
Pediatr Blood Cancer; 2005 Nov; 45(6):796-801. PubMed ID: 15602716
[TBL] [Abstract][Full Text] [Related]
79. Head and neck inflammatory myofibroblastic tumor (IMT): evaluation of clinicopathologic and prognostic features.
Ong HS; Ji T; Zhang CP; Li J; Wang LZ; Li RR; Sun J; Ma CY
Oral Oncol; 2012 Feb; 48(2):141-8. PubMed ID: 22014665
[TBL] [Abstract][Full Text] [Related]
80. Cutaneous inflammatory myofibroblastic tumours can be anaplastic lymphoma kinase-positive: report of the first four cases.
Leguellec S; Tournier E; Karanian M; Brousset P; Mazereeuw J; Coindre JM; Lamant L
Histopathology; 2016 Jan; 68(2):297-302. PubMed ID: 26100036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
